China is not one supplement market but two, and the choice between them is the single biggest decision you will make. One route takes two to five years and costs six figures. The other takes six to twelve weeks. They reach different shelves, permit different claims, and demand entirely different dossiers.
Most Korean brands should start with the second and only consider the first once volume justifies it. This page explains why, and what each route actually requires.
It is general regulatory information, not legal advice.
| Domestic (general trade) | Cross-border e-commerce (CBEC) | |
|---|---|---|
| Legal basis | Health Food (保健食品) under the Food Safety Law | Personal import for own use |
| Approval | Blue Hat registration or filing | None |
| Chinese entity | Required | Not required |
| Timeline | Registration 2–5 years; filing 6–12 months | 6–12 weeks to launch |
| Cost per SKU | USD 50,000–200,000+ for registration | Comparatively minimal |
| Where it sells | Pharmacies, supermarkets, hospitals, general retail | Tmall Global, JD Worldwide, Kaola, Douyin Global |
| Chinese label | Required, GB standards | Not required |
| Health claims | Permitted, within approved wording | Not permitted |
The domestic route is administered by SAMR (State Administration for Market Regulation); the Blue Hat mark on the package is its visible sign. CBEC operates under a separate regime built around bonded warehouses, a positive list and per-consumer purchase caps.
Within the domestic channel there are two sub-tracks, and confusing them is expensive.
Available only for products whose ingredients appear in the Health Food Raw Material Catalogue and whose claims match the filing-permitted function list. The 2023 edition covers 85 nutrient supplement entries plus a small number of functional raw materials — including coenzyme Q10, melatonin, fish oil and spirulina.
For a Korean vitamin, mineral, omega-3 or CoQ10 product, this is usually the realistic domestic option — if the formula matches the catalogue exactly. A single off-catalogue ingredient pushes you to full registration.
Mandatory for products claiming one of the functions in the health-function directory (immunity, digestion, sleep quality and so on), for products using active ingredients outside the raw material catalogue, and generally for first-time imports of novel formulations.
The cost is per SKU, not per company. A ten-product line does not amortise.
CBEC treats the purchase as a personal import by the consumer. That classification is what removes Blue Hat from the equation — the product is not being "placed on the Chinese market" in the regulatory sense.
What you still must satisfy:
which covers over 1,400 categories as of 2026. Vitamins and minerals, fish oil and omega-3, probiotics, collagen peptides, CoQ10, melatonin, glucosamine and herbal extracts are broadly covered — most standard Korean formulations fall inside it, but check your specific product rather than assuming
serves this purpose directly
This catches brands out: the exemption is from Blue Hat registration, not from claim rules
"CBEC means no regulation" is the most common and most costly misunderstanding. It reduces requirements; it does not remove them.
Overseas food manufacturers exporting to China generally must register their production facility with the General Administration of Customs (GACC). Decree 280 took effect on 1 June 2026, replacing the Decree 248 framework.
For supplements the current position is favourable but explicitly provisional: products imported through cross-border retail are not presently required to complete overseas manufacturer registration.
Two cautions:
Hat or filing, your Korean factory must be registered regardless.
involving counterfeit foreign-brand products, Chinese authorities have described their posture toward health foods sold via cross-border as increasingly cautious, and have indicated policy may be further tightened.
The practical read: treat the CBEC exemption as a window rather than a permanent feature. If your Korean manufacturer can obtain GACC registration without much friction, doing so early hedges against a rule change mid-programme.
Effective 1 February 2026, China's livestream e-commerce rules prohibit sale of health food, pharmaceuticals and formula food for special medical purposes through KOL/influencer livestreaming. Brand-owned livestreaming and professional educational content remain permitted.
This matters commercially more than it looks. Influencer livestreaming has been a primary customer-acquisition channel for imported supplements on Chinese platforms. If your distributor's plan rests on KOL livestreams, that plan needs revisiting — and the revision belongs in the discussion before you sign a volume commitment.
CBEC: exempt from Chinese labelling requirements. The Korean label may remain, though platforms typically require a Chinese-language product description.
Domestic: a compliant Chinese label under GB 7718 and related standards is required, carrying the Blue Hat mark and approval number where applicable. Korean MFDS-approved claim wording does not transfer and must be replaced with the wording approved in your Chinese filing or registration.
The advice is consistent across regulatory consultancies working this market:
Start with CBEC. Build sales volume and brand recognition on Tmall Global and JD Worldwide over two to three years, then apply for Blue Hat on your top-selling SKUs once the business case is proven. Registration cost is bearable when applied to a product with demonstrated demand; it is not when applied speculatively across a catalogue.
Go Blue Hat first only when you have a large-volume B2B opportunity (corporate wellness, hospital or pharmacy channel), your distribution partner requires it, or your category sells primarily offline.
The two are not mutually exclusive — many brands run both, using CBEC for commercial learning while building the dossier that opens general trade.
| Stage | CBEC | Domestic (filing) | Domestic (registration) |
|---|---|---|---|
| Positive list / catalogue check | Days | 1–2 weeks | 1–2 weeks |
| Chinese entity setup | Not required | Weeks to months | Weeks to months |
| GACC facility registration | Currently exempt | Required | Required |
| Testing and dossier | Minimal | 2–4 months | 6 months+ |
| Authority review | — | 6–12 months in practice | 2–5 years |
| To first sale | 6–12 weeks | ~1 year | 2–5 years |
Catalogue** — one off-catalogue ingredient means registration, not filing
currently exempt for your route
healthcito.com compiles publicly available regulatory information. Reviewed 11 August 2026. This page is general information, not legal advice. Chinese cross-border policy is actively changing and the supplement exemption under Decree 280 is described by regulators as provisional — confirm current requirements with GACC, SAMR or a licensed consultant before acting. Supported by GNMLIFE, Inc.
Last reviewed: